Free Trial

Oscar Gruss Analyst Recommendations & Stock Picks

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Oscar Gruss. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Oscar Gruss.

MarketRank™ evaluates a company based on dividend strength, earnings, valuation, analysts forecasts, and more.
Available with a MarketBeat All Access Subscription
MarketRank™Upgrade to All Access to use the All Ranks Filter
Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.
Available with a MarketBeat All Access Subscription
Media SentimentUpgrade to All Access to use the All Sentiments Filter
Analyst consensus is the average investment recommendation among Wall Street research analysts.
Available with a MarketBeat All Access Subscription
Analyst ConsensusUpgrade to All Access to use the All Ratings Filter
CompanyCurrent PriceRating DateActionBrokerageAnalystRatingPrice TargetImpact on PriceDetailsActions
Pentair stock logo
PNR
Pentair
$101.95
+1.0%
6/28/2012Initiated byOscar Gruss-BuyN/AView details for Oscar Gruss rating of Pentair (NYSE:PNR) on 6/28/2012
WW International stock logo
WW
WW International
$1.34
-2.9%
4/10/2012Downgraded byOscar Gruss-SellN/AView details for Oscar Gruss rating of WW International (NASDAQ:WW) on 4/10/2012
WW International stock logo
WW
WW International
$1.34
-2.9%
2/23/2012Initiated byOscar Gruss-HoldN/AView details for Oscar Gruss rating of WW International (NASDAQ:WW) on 2/23/2012
SunCoke Energy stock logo
SXC
SunCoke Energy
$10.94
-0.5%
12/22/2011Initiated byOscar Gruss-HoldN/AView details for Oscar Gruss rating of SunCoke Energy (NYSE:SXC) on 12/22/2011
Beam Therapeutics stock logo
BEAM
Beam Therapeutics
$29.01
+8.0%
12/2/2011Downgraded byOscar Gruss-ReduceN/AView details for Oscar Gruss rating of Beam Therapeutics (NASDAQ:BEAM) on 12/2/2011

MarketBeat Community Rating for Oscar Gruss

Community Ranking:  2.6 out of 5 (
2.6 of 5 stars)
Outperform Votes:  33,832 (Vote Outperform)
Underperform Votes:  30,568 (Vote Underperform)
Total Votes:  64,400
MarketBeat's community ratings are surveys of what our community members think about Oscar Gruss and other research firms. Vote "Outperform" if you believe Oscar Gruss's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Oscar Gruss's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days.